Estrogens and selective estrogen receptor modulators regulate gene and protein expression in the mesenteric arteries

Vascular Pharmacology

Volumn 55, Issue 1-3, 2011, Pages 42-49

  Mark Kappeler, Connie J ^a   Martin, Douglas S ^a   Eyster, Kathleen M ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Equilin; Ethinyl estradiol; Microarray; Raloxifene; Tamoxifen

Indexed keywords

ACYL COENZYME A DESATURASE; EPOXIDE HYDROLASE; EQUILIN; ESTRADIOL BENZOATE; ETHINYLESTRADIOL; FATTY ACID SYNTHASE; PHOSPHOLIPASE A2 GROUP IB; RALOXIFENE; SECRETED FRIZZLED RELATED PROTEIN 4; SOLUBLE EPOXIDE HYDROLASE; SOMATOMEDIN C; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DNA MICROARRAY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; MESENTERIC ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MESENTERIC ARTERIES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BIOSYNTHESIS; RALOXIFENE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 80051780913     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.05.002     Document Type: Article

References (56)

1. Arnqvist H.J., Bornfeldt K.E., Chen Y., Lindstrom T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 1995, 44(10 Suppl 4):58-66.
2. Bayes-Genis A., Conover C.A., Schwartz R.S. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ. Res. 2000, 86:125-130.
3. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 2001, 29(4):365-371.
4. Browne C.D., Hindmarsh E.J., Smith J.W. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. FASEB J. 2006, 20(12):2027-2035.
5. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 1996, 78(3):415-423.
6. Carluccio M.A., Massaro M., Bonfrate C., Siculella L., Maffia M., Nicolardi G., Distante A., Storelli C., De Caterina R. Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the Mediterranean diet. Arterioscler. Thromb. Vasc. Biol. 1999, 19(2):220-228.
7. Christensen K.L., Mulvany M.J. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J. Vasc. Res. 1993, 30(2):73-79.
8. Clarkson T.B. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 2007, 14:373-384.
9. Conti E., Carrozza C., Capoluongo E., Volpe M., Crea F., Zuppi C., Andreotti F. Insulin-like growth factor-I as a vascular protective factor. Circulation 2004, 110:2260-2265.
10. Cuzick J., Powles T., Veronesi U., Forbes J., Edwards R., Ashley S., Boyle P. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003, 361:296-300.
11. Decensi A., Maisonneuve P., Rotmensz N., Bettega D., Costa A., Sacchini V., Salvioni A., Travaglini R., Oliviero P., D'Aiuto G., Gulisano M., Gucciardo G., del Turco M.R., Pizzichetta M.A., Conforti S., Bonanni B., Boyle P., Veronesi U. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation 2005, 111:650-656.
12. Delafontaine P., Song Y.H., Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 2004, 24(3):435-444.
13. Dubey R.K., Jackson E.K. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am. J. Physiol. Renal Physiol. 2001, 280:F365-F388.
14. Dubey R.K., Imthurn B., Barton M., Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 2005, 66:295-306.
15. Eyster K.M., Mark C.J., Gayle R., Martin D.S. The effects of estrogen and testosterone on gene expression in the rat mesenteric arteries. Vascul. Pharmacol. 2007, 47(4):238-247.
16. Gao H., Liang M., Bergdahl A., Hamren A., Lindholm M.W., Dahlman-Wright K., Nilsson B.-O. Estrogen attenuates vascular expression of inflammation associated genes and adhesion of monocytes to endothelial cells. Inflamm. Res. 2006, 55:349-353.
17. Goodwin A.M., D'Amore P.A. Wnt signaling in the vasculature. Angiogenesis 2002, 5(1-2):1-9.
18. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8(2):R19.
19. Hu S., Kim H.S. Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur. J. Pharmacol. 1993, 230(2):215-221.
20. Imig J.D. Targeting epoxides for organ damage in hypertension. J. Cardiovasc. Pharmacol. 2010, 56:329-335.
21. Jones S.E., Jomary C. Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays 2002, 24(9):811-820.
22. Leung F.P., Tsang S.Y., Wong C.M., Yung L.M., Chan Y.C., Leung H.S., Yao X., Huang Y. Raloxifene, tamoxifen, and vascular tone. Clin. Exp. Pharmacol. Physiol. 2007, 34:809-813.
23. Lewiecki E.M. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. J. Womens Health (Larchmt.) 2009, 18:1615-1626.
24. Li M., Stallone J.N. Estrogen potentiates vasopressin-induced contraction of female rat aorta by enhancing cyclooxygenase-2 and thromboxane function. Am. J. Physiol. Heart Circ. Physiol. 2005, 289(4):H1542-1550.
25. Li J., Carroll M.A., Chander P.N., Falck J.R., Sangran B., Stier C.T. Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension. Front. Biosci. 2008, 13:3480-3487.
26. Li M., Kuo L., Stallone J.N. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am. J. Physiol. Heart Circ. Physiol. 2008, 294(6):H2444-2455.
27. Ling S., Komesaroff P., Sudhir K. Cellular mechanisms underlying the cardiovascular actions of oestrogens. Clin. Sci. (Lond.) 2006, 111(2):107-118.
28. Mark C.J., Tatchum-Talom R., Martin D.S., Eyster K.M. Effects of estrogens and selective estrogen receptor modulators (SERMs) on vascular reactivity in the perfused mesenteric vascular bed. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1969-R1975.
29. McCallum R.W., Hamilton C.A., Graham D., Jardine E., Connel J.M.C., Dominiczak A.F. Vascular responses to IGF-I and insulin are impaired in aortae of hypertensive rats. J. Hypertens. 2005, 23:351-358.
30. Miller V.M., Duckles S.P. Vascular actions of estrogens: functional implications. Pharmacol. Rev. 2008, 60:210-241.
31. Nakamura Y., Igarashi K., Suzuki T., Kanno J., Inoue T., Tazawa C., Saruta M., Ando T., Moriyama N., Furukawa T., Ono M., Moriya T., Ito K., Saito H., Ishibashi T., Takahashi S., Yamada S., Sasano H. E4F1, a novel estrogen-responsive gene in possible atheroprotection, revealed by microarray analysis. Am. J. Pathol. 2004, 165:2019-2031.
32. Nilsson S., Koehler K.F. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology. Basic Clin. Pharmacol. Toxicol. 2005, 96:15-25.
33. Node K., Huo Y., Ruan X., Yang B., Spiecker M., Ley K., Zeldin D.C., Liao J.K. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999, 285(5431):1276-1279.
34. Okano H., Jayachandran M., Yoshikawa A., Miller V.M. Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthease in porcine aortic endothelial cells. J. Cardiovasc. Pharmacol. 2006, 47:621-628.
35. Olearczyk J.J., Field M.B., Kim I.H., Morisseau C., Hammock B.D., Imig J.D. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels. J. Pharmacol. Exp. Ther. 2006, 318(3):1307-1314.
36. Paton C.M., Ntambi J.M. Biochemical and physiological function of stearoyl-CoA desaturase. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E28-E37.
37. Pete G., Hu Y., Walsh M., Sowers J., Dunbar J.C. Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc. Soc. Exp. Biol. Med. 1996, 213(2):187-192.
38. Qin X., Tian J., Zhang P., Fan Y., Chen L., Guan Y., Fu Y., Zhu Y., Chien S., Wang N. Laminar shear stress up-regulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cells. Cardiovasc. Res. 2007, 74(3):506-514.
39. Rodrigo M.C., Martin D.S., Redetzke R.A., Eyster K.M. A method for the extraction of high-quality RNA and protein from single small samples of arteries and veins preserved in RNAlater. J. Pharmacol. Toxicol. Methods 2002, 47(2):87-92.
40. Rodrigo M.C., Martin D.S., Eyster K.M. Estrogen decreases biglycan mRNA expression in resistance blood vessels. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R754-R761.
41. Rodrigo M.C., Martin D.S., Eyster K.M. Vascular ECE-1 mRNA expression decreases in response to estrogens. Life Sci. 2003, 73:2973-2983.
42. Sato M., Rippy M.K., Bryant H.U. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J. 1996, 10(8):905-912.
43. Scheidegger K.J., Cenni B., Picard D., Delafontaine P. Estradiol decreases IGF-1 and IGF-1 receptor expression in rat aortic smooth muscle cells. Mechanisms for its atheroprotective effects. J. Biol. Chem. 2000, 275(49):38921-38928.
44. Seth J.K., Vidal-Puig A. Wnt signalling and the control of cellular metabolism. Biochem. J. 2010, 427:1-17.
45. Shankar S.S., Steinberg H.O. FFAs: do they play a role in vascular disease in the insulin resistance syndrome?. Curr. Diab. Rep. 2005, 5(1):30-35.
46. Smith S., Witkowski A., Joshi A.K. Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res. 2003, 42(4):289-317.
47. Stepniakowski K.T., Sallee F.R., Goodfriend T.L., Zhang Z., Egan B.M. Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. Am. J. Physiol. 1996, 270(6 Pt 2):R1340-R1346.
48. Sun D., Yang Y.M., Jiang H., Wu H., Ojaimi C., Kaley G., Huang A. Roles of CYP2C29 and RXR gamma in vascular EET synthesis of female mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R862-R869.
49. Swartz C.D., Afshari C.A., Yu L., Hall K.E., Dixon D. Estrogen-induced changes in IGF-I, Myb family, and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol. Hum. Reprod. 2005, 11:441-450.
50. Verheij H.M., Slotboom A.J., de Haas G.H. Structure and function of phospholipase A2. Rev. Physiol. Biochem. Pharmacol. 1981, 91:91-203.
51. Watanabe T., Akishita M., Nakaoka T., He H., Miyahara Y., Yamashita N., Wada Y., Aburatani H., Yoshizumi M., Kozaki K., Ouchi Y. Caveolin-1, Id2a and two LIM protein genes are upregulated by estrogen in vascular smooth muscle cells. Life Sci. 2004, 75:1219-1229.
52. Weisinger G., Gavish M., Mazurika C., Zinder O. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: tissue- and treatment-specificity. Biochim. Biophys. Acta 1999, 1446(3):225-232.
53. Xing D., Nozell S., Chan Y.-F., Hage F., Oparil S. Estrogen and mechanisms of vascular protection. Arterioscler. Thromb. Vasc. Biol. 2009, 29:289-295.
54. Zeldin D.C., Kobayashi J., Falck J.R., Winder B.S., Hammock B.D., Snapper J.R., Capdevila J.H. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 1993, 268(9):6402-6407.
55. Zerlin M., Julius M.A., Kitajewski J. Wnt/Frizzled signaling in angiogenesis. Angiogenesis 2008, 11:63-69.
56. Zhao G., Sutliff R.L., Weber C.S., Wang J., Lorenz J., Paul R.J., Fagin J.A. Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility. Endocrinology 2001, 142(2):623-632.